The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 24,555,575 | 1,590,387 | SH | SOLE | NONE | 1,590,387 | 0 | 0 | ||
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 5,273,911 | 967,690 | SH | SOLE | NONE | 967,690 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 7,126,944 | 6,307,030 | SH | SOLE | NONE | 6,307,030 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 26,400,298 | 4,074,120 | SH | SOLE | NONE | 4,074,120 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 38,230,033 | 125,213 | SH | SOLE | NONE | 125,213 | 0 | 0 | ||
ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 02081GAB8 | 43,099,844 | 44,750,000 | PRN | SOLE | NONE | 44,750,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 5,999,520 | 1,249,900 | SH | SOLE | NONE | 1,249,900 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 9,729,112 | 36,200 | SH | SOLE | NONE | 36,200 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 18,854,821 | 1,049,823 | SH | SOLE | NONE | 1,049,823 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 10,460,707 | 491,113 | SH | SOLE | NONE | 491,113 | 0 | 0 | ||
ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 | 04351PAD3 | 113,770,000 | 124,000,000 | PRN | SOLE | NONE | 124,000,000 | 0 | 0 | ||
AXONICS INC | COM | 05465P101 | 19,896,055 | 354,527 | SH | SOLE | NONE | 354,527 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 25,913,528 | 1,289,872 | SH | SOLE | NONE | 1,289,872 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 37,969,898 | 5,362,980 | SH | SOLE | NONE | 5,362,980 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 61,504,080 | 1,164,850 | SH | SOLE | NONE | 1,164,850 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 109,764,480 | 114,338,000 | PRN | SOLE | NONE | 114,338,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 50,470,500 | 67,294,000 | PRN | SOLE | NONE | 67,294,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 11,729,918 | 5,954,273 | SH | SOLE | NONE | 5,954,273 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 17,275,228 | 1,908,865 | SH | SOLE | NONE | 1,908,865 | 0 | 0 | ||
CUTERA INC | NOTE 2.250% 6/0 | 232109AD0 | 19,980,660 | 33,900,000 | PRN | SOLE | NONE | 33,900,000 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 19,153,320 | 77,200 | SH | SOLE | NONE | 77,200 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 45,590,081 | 3,715,573 | SH | SOLE | NONE | 3,715,573 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 16,466,588 | 12,107,785 | SH | SOLE | NONE | 12,107,785 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 42,436,731 | 3,336,221 | SH | SOLE | NONE | 3,336,221 | 0 | 0 | ||
DEXCOM INC | NOTE 0.250%11/1 | 252131AK3 | 35,531,250 | 37,500,000 | PRN | SOLE | NONE | 37,500,000 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 16,324,869 | 1,821,972 | SH | SOLE | NONE | 1,821,972 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 11,597,923 | 1,038,310 | SH | SOLE | NONE | 1,038,310 | 0 | 0 | ||
EXACT SCIENCES CORP | NOTE 0.375% 3/0 | 30063PAC9 | 113,721,100 | 131,000,000 | PRN | SOLE | NONE | 131,000,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 52,358,348 | 695,792 | SH | SOLE | NONE | 695,792 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 20,421,960 | 689,000 | SH | SOLE | NONE | 689,000 | 0 | 0 | ||
GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 185,764,510 | 268,252,000 | PRN | SOLE | NONE | 268,252,000 | 0 | 0 | ||
HARROW INC | COM | 415858109 | 25,990,789 | 1,808,684 | SH | SOLE | NONE | 1,808,684 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 19,492,359 | 1,449,246 | SH | SOLE | NONE | 1,449,246 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 47,071,899 | 906,973 | SH | SOLE | NONE | 906,973 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 17,036,373 | 294,900 | SH | SOLE | NONE | 294,900 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 39,723,222 | 39,963,000 | PRN | SOLE | NONE | 39,963,000 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 19,903,532 | 100,300 | SH | SOLE | NONE | 100,300 | 0 | 0 | ||
INSULET CORP | NOTE 0.375% 9/0 | 45784PAK7 | 53,573,500 | 54,500,000 | PRN | SOLE | NONE | 54,500,000 | 0 | 0 | ||
INTEGRA LIFESCIENCES HLDGS C | NOTE 0.500% 8/1 | 457985AM1 | 13,296,500 | 14,500,000 | PRN | SOLE | NONE | 14,500,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 33,589,967 | 114,920 | SH | SOLE | NONE | 114,920 | 0 | 0 | ||
INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 14,850,082 | 16,781,000 | PRN | SOLE | NONE | 16,781,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 51,764,310 | 52,740,000 | PRN | SOLE | NONE | 52,740,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 53,554,479 | 568,157 | SH | SOLE | NONE | 568,157 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 12,982,193 | 1,348,099 | SH | SOLE | NONE | 1,348,099 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 | 46333XAF5 | 37,250,188 | 37,509,000 | PRN | SOLE | NONE | 37,509,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | NOTE 1.500% 6/1 | 46333XAH1 | 15,141,950 | 15,500,000 | PRN | SOLE | NONE | 15,500,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 40,943,996 | 65,976,000 | PRN | SOLE | NONE | 65,976,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 43,271,011 | 1,357,309 | SH | SOLE | NONE | 1,357,309 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 8,989,652 | 77,497 | SH | SOLE | NONE | 77,497 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 20,031,084 | 288,300 | SH | SOLE | NONE | 288,300 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 59,080,314 | 879,564 | SH | SOLE | NONE | 879,564 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 39,748,570 | 3,974,857 | SH | SOLE | NONE | 3,974,857 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 0 | 1,901,337 | SH | SOLE | NONE | 1,901,337 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 19,247,289 | 2,023,900 | SH | SOLE | NONE | 2,023,900 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 112,369,466 | 145,520,000 | PRN | SOLE | NONE | 145,520,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 44,787,416 | 1,012,145 | SH | SOLE | NONE | 1,012,145 | 0 | 0 | ||
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 26,250,000 | 28,000,000 | PRN | SOLE | NONE | 28,000,000 | 0 | 0 | ||
NEOGENOMICS INC | NOTE 0.250% 1/1 | 64049MAB6 | 45,191,662 | 62,601,000 | PRN | SOLE | NONE | 62,601,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 108,902,700 | 968,024 | SH | SOLE | NONE | 968,024 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 34,141,793 | 1,776,368 | SH | SOLE | NONE | 1,776,368 | 0 | 0 | ||
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 102,018,584 | 109,251,000 | PRN | SOLE | NONE | 109,251,000 | 0 | 0 | ||
NOVOCURE LTD | NOTE 11/0 | 67011XAB9 | 118,012,579 | 135,834,000 | PRN | SOLE | NONE | 135,834,000 | 0 | 0 | ||
NUVASIVE INC | NOTE 0.375% 3/1 | 670704AJ4 | 56,647,490 | 61,340,000 | PRN | SOLE | NONE | 61,340,000 | 0 | 0 | ||
ORTHOPEDIATRICS CORP | COM | 68752L100 | 33,848,640 | 1,057,770 | SH | SOLE | NONE | 1,057,770 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 26,116,646 | 2,400,427 | SH | SOLE | NONE | 2,400,427 | 0 | 0 | ||
PARAGON 28 INC | COM | 69913P105 | 42,190,891 | 3,361,824 | SH | SOLE | NONE | 3,361,824 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 23,057,652 | 95,315 | SH | SOLE | NONE | 95,315 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 10,862,111 | 331,061 | SH | SOLE | NONE | 331,061 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 18,500,622 | 1,109,150 | SH | SOLE | NONE | 1,109,150 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 10,211,814 | 988,559 | SH | SOLE | NONE | 988,559 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 17,991,349 | 1,082,512 | SH | SOLE | NONE | 1,082,512 | 0 | 0 | ||
RAYZEBIO INC | COM | 75525N107 | 6,166,672 | 277,778 | SH | SOLE | NONE | 277,778 | 0 | 0 | ||
REPLIGEN CORP | COM | 759916109 | 18,826,784 | 118,400 | SH | SOLE | NONE | 118,400 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 8,341,467 | 487,520 | SH | SOLE | NONE | 487,520 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | NOTE 1.250% 9/1 | 803607AD2 | 49,549,835 | 44,166,000 | PRN | SOLE | NONE | 44,166,000 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 9,015,739 | 42,497 | SH | SOLE | NONE | 42,497 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 14,285,462 | 2,840,052 | SH | SOLE | NONE | 2,840,052 | 0 | 0 | ||
THE BEAUTY HEALTH COMPANY | COM CL A | 88331L108 | 9,789,941 | 1,626,236 | SH | SOLE | NONE | 1,626,236 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 38,341,871 | 75,749 | SH | SOLE | NONE | 75,749 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | 10,569,002 | 1,653,991 | SH | SOLE | NONE | 1,653,991 | 0 | 0 | ||
TRANSMEDICS GROUP INC | COM | 89377M109 | 16,819,200 | 307,200 | SH | SOLE | NONE | 307,200 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 48,220,279 | 56,031,000 | PRN | SOLE | NONE | 56,031,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 18,393,480 | 28,350,000 | PRN | SOLE | NONE | 28,350,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 82,564,812 | 1,619,553 | SH | SOLE | NONE | 1,619,553 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 26,617,692 | 1,735,182 | SH | SOLE | NONE | 1,735,182 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 71,852,007 | 2,103,396 | SH | SOLE | NONE | 2,103,396 | 0 | 0 |